NEUROGENE INC(NGNE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NGNE NEUROGENE INC

Not Yet Opened 07-06 16:00:00 EDT

32.56

-2.78

-7.87%

盘后32.96

+0.40+1.23%

19:29 EDT

High36.04	Low32.42	Vol230.21K
Open35.23	D1 Closing35.34	Amplitude10.23%
Mkt Cap644.12M	Tradable Cap536.52M	Total Shares19.78M
T/O7.71M	T/O Rate1.40%	Tradable Shares16.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":32.56,"timestamp":1783368000000,"preClose":35.34,"halted":0,"volume":230214,"hourTrading":{"tag":"盘后","latestPrice":32.96,"preClose":32.56,"latestTime":"19:29 EDT","volume":1645,"amount":53777.71,"timestamp":1783380588571,"change":0.4,"changeRate":0.012285,"amplitude":0.012285},"delay":0,"changeRate":-0.078664402942841,"floatShares":16477892,"shares":19782500,"eps":-4.557199,"marketStatus":"Not Yet Opened","change":-2.78,"latestTime":"07-06 16:00:00 EDT","open":35.23,"high":36.035,"low":32.42,"amount":7710271.115784001,"amplitude":0.102292,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.557199,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783411200000},"marketStatusCode":0,"adr":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":35.34,"preHourTrading":{"tag":"盘前","latestPrice":35.97,"preClose":35.34,"latestTime":"09:11 EDT","volume":46,"amount":1661.009998,"timestamp":1783343490405,"change":0.63,"changeRate":0.017827,"amplitude":0.064799},"postHourTrading":{"tag":"盘后","latestPrice":32.96,"preClose":32.56,"latestTime":"19:29 EDT","volume":1645,"amount":53777.71,"timestamp":1783380588571,"change":0.4,"changeRate":0.012285,"amplitude":0.012285},"volumeRatio":0.510098,"impliedVol":0.9738,"impliedVolPercentile":0.464},"requestUrl":"/m/hq/s/NGNE/tweets","defaultTab":"tweets","newsList":[{"id":"2649679980","title":"Neurogene Grants Inducement Stock Options for 96,450 Shares to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679980?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:01","pubTimestamp":1783368075,"startTime":"0","endTime":"0","summary":"Neurogene grants inducement stock options for 96,450 shares to new employeesNeurogene adopted inducement equity awards under its 2025 Inducement Plan, granting options for 96,450 common shares to six ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL8PNHYg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679664","title":"Neurogene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679664?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:01","pubTimestamp":1783368060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA6NF6PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648320639","title":"Neurogene President, CFO Christine Mikail Cvijic Sells 4,800 Common Shares for $166,407.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2648320639","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648320639?lang=en_us&edition=fundamental","pubTime":"2026-07-03 06:43","pubTimestamp":1783032214,"startTime":"0","endTime":"0","summary":"Neurogene President, CFO Christine Mikail Cvijic sells 4,800 common shares for $166,407.28Neurogene President and CFO Christine Mikail Cvijic sold 4,800 common shares on July 1-2.Sales priced at USD 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL4s8c0k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurogene President, CFO Christine Mikail Cvijic Sells 4,800 Common Shares for $166,407.28","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648325509","title":"Neurogene Says Cash Runway Extends into Q1 2029 After USD 134.8 Million Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648325509","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648325509?lang=en_us&edition=fundamental","pubTime":"2026-07-02 18:04","pubTimestamp":1782986661,"startTime":"0","endTime":"0","summary":"Neurogene says cash runway extends into Q1 2029 after USD 134.8 million stock offeringNeurogene mapped out a longer operating runway into the first quarter of 2029 following a public equity offering expected to generate about $134.8 million in net proceeds.The financing centers on 3,500,000 common shares priced at USD 30 per share.It also includes pre-funded warrants covering up to 666,666 shares priced at USD 30 per share, net of a USD 0.000001 exercise price.Underwriters exercised in full a 30-day option for an additional 624,999 shares, with the deal set to close July 2.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gatherin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDLb9Jnm0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648542387","title":"U.S. Stocks on the Move-general Mills, Meta, Lockheed Martin","url":"https://stock-news.laohu8.com/highlight/detail?id=2648542387","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648542387?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:37","pubTimestamp":1782920279,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-General Mills, Meta, Lockheed MartinWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nL6N43311T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRMG","KLAC","HON","OPTU","APP","ABR","COIN","CRCG","SOC","CRM","KR","SDOT","NEMG","AA","SHEL.UK","NGNE","TERG","INLF","GIS","S32.AU","LHAI","WDAY","TALO","APPX","NKE","META","ALIT","LMT","OKLO","KLAR","TER","SSTK","NEM","OKLL","KLAG","BE","PNBK","MSM","LIME","BSP","AU","GLW","LION","SKYQ","NOW","GRND","RFL","COII","CRCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648517879","title":"Neurogene Prices USD 125 Million Follow-on Stock Offering at USD 30 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2648517879","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648517879?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:00","pubTimestamp":1782903625,"startTime":"0","endTime":"0","summary":"Neurogene prices USD 125 million follow-on stock offering at USD 30 per shareNeurogene priced a public offering expected to raise about USD 125 million in gross proceeds.Deal includes 3,500,000 common","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL9wKxy2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648251207","title":"Neurogene - Prices Public Offering of 3.5 Mln Shares at $30 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2648251207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648251207?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:00","pubTimestamp":1782903600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nTUA5LT1CQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562189","title":"Neurogene to Sell Shares in Secondary Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562189","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648562189?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:52","pubTimestamp":1782852720,"startTime":"0","endTime":"0","summary":"Neurogene filed to sell shares in a public offering.The clinical-stage biotechnology company didn't specify how many shares it plans to sell or at what price, according to a filing with the Securities","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648564904","title":"Neurogene Inc: Files for Offering of Common Stock, Pre-funded Warrants to Buy Common Stock; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564904","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564904?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:21","pubTimestamp":1782850912,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN4320WD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648645115","title":"Neurogene Drops After Starting Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648645115","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648645115?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:18","pubTimestamp":1782850704,"startTime":"0","endTime":"0","summary":"BUZZ-Neurogene drops after starting equity offering** Shares of gene therapy developer NeurogeneNGNE.Odown 4.6% post-market to $30 as it seeks equity raise** Neurological diseases-focused NGNE commenc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nL6N43219N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648564980","title":"Neurogene announces common stock offering, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2648564980","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648564980?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:11","pubTimestamp":1782850263,"startTime":"0","endTime":"0","summary":"Neurogene (NGNE) announced that it has commenced a public offering of shares of its common stock or, in lieu of common stock to certain investors t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-announces-common-stock-offering-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648614425","title":"Neurogene Commences Public Offering of Common Stock, Pre-funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2648614425","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648614425?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:01","pubTimestamp":1782849687,"startTime":"0","endTime":"0","summary":"Neurogene commences public offering of common stock, pre-funded warrantsNeurogene launched a public offering of common stock; some investors may opt for pre-funded warrants instead of shares.Underwrit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL8vJjKc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4207","BK4127","MNSH","SF","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648614835","title":"Neurogene Inc. Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648614835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648614835?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:01","pubTimestamp":1782849660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA7HSLCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648561104","title":"Neurogene - Proceeds to Fund Ngn-401 Development, Pre-commercial Activities, and General Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2648561104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648561104?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:01","pubTimestamp":1782849660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nTUA7HSLCB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647558737","title":"Guggenheim Reaffirms Their Buy Rating on Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647558737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647558737?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:35","pubTimestamp":1782819347,"startTime":"0","endTime":"0","summary":"In a report released today, Debjit Chattopadhyay from Guggenheim maintained a Buy rating on Neurogene, with a price target of $69.00. Chattopadhyay...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647377969","title":"Analysts’ Top Healthcare Picks: ProQR (PRQR), Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647377969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647377969?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:40","pubTimestamp":1782740409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ProQR (PRQR) and Neurogene (NGNE) with bullish senti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-proqr-prqr-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-proqr-prqr-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","LABU","XLV","PRQR","NGNE","LU0029874061.USD","HCSG","LU0128526141.USD","XBI","BK4588","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647037548","title":"Neurogene Says Ngn-401 Gene Therapy Shows Sustained Rett Syndrome Milestone Gains in Phase 1/2 Trial Through 30 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2647037548","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647037548?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730843,"startTime":"0","endTime":"0","summary":"Neurogene says NGN-401 gene therapy shows sustained Rett syndrome milestone gains in Phase 1/2 trial through 30 monthsNeurogene reported positive long-term Phase 1/2 data for NGN-401 gene therapy in f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL8XYRvf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647936375","title":"Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2647936375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647936375?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA1LLC8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647119375","title":"Neurogene - Ngn-401 Generally Well-tolerated at 1E15 Vg Dose as of June 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647119375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647119375?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA1LLC8W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289034","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) and Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289034?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:21","pubTimestamp":1781176915,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-heartflow-inc-htfl-and-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-heartflow-inc-htfl-and-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","NGNE","XBI","LU0122379950.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0128526141.USD","LU0266013472.USD","BK4137","SG9999004303.SGD","LU1057294990.SGD","LU1989763427.SGD","IE00BJJMRZ35.SGD","BK4568","SGXZ23171101.USD","LU0170899867.USD","LU1914381329.SGD","LU1989763690.USD","HCSG","BK4139","LU1061106388.HKD","LU0058720904.USD","LU2237957811.SGD","BK4566","BK4533","HTFL","SG9999002232.USD","ABT","BK4581","LU2089984988.USD","LU1023059063.AUD","LABU","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0234572021.USD","BK4167","LU2133065610.SGD","BK4082","SGXZ41872573.SGD","LU1721429402.USD","LU0289739699.SGD","LU1691799644.USD","LU2211815571.USD","BK4504","LU0868494617.USD","SG9999002224.SGD","XLV","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurogene.com","stockEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.2291},{"period":"3month","weight":0.5571},{"period":"6month","weight":0.7029},{"period":"1year","weight":0.6207},{"period":"ytd","weight":0.5806}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.1396},{"period":"6month","weight":0.0895},{"period":"1year","weight":0.2014},{"period":"ytd","weight":0.1017}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.03558},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.018567},{"month":3,"riseRate":0.416667,"avgChangeRate":0.022217},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.048366},{"month":5,"riseRate":0.538462,"avgChangeRate":0.007464},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.058237},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.048083},{"month":8,"riseRate":0.833333,"avgChangeRate":0.776521},{"month":9,"riseRate":0.25,"avgChangeRate":-0.065331},{"month":10,"riseRate":0.416667,"avgChangeRate":0.020322},{"month":11,"riseRate":0.416667,"avgChangeRate":0.000025},{"month":12,"riseRate":0.583333,"avgChangeRate":0.147487}],"exchange":"NASDAQ","name":"NEUROGENE INC","nameEN":"NEUROGENE INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NEUROGENE INC(NGNE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest NEUROGENE INC(NGNE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"NEUROGENE INC,NGNE,NEUROGENE INC股票,NEUROGENE INC股票老虎,NEUROGENE INC股票老虎国际,NEUROGENE INC行情,NEUROGENE INC股票行情,NEUROGENE INC股价,NEUROGENE INC股市,NEUROGENE INC股票价格,NEUROGENE INC股票交易,NEUROGENE INC股票购买,NEUROGENE INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NEUROGENE INC(NGNE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest NEUROGENE INC(NGNE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}